@Hadrian. If the directors are keen to sell the company at this price I am sure the report is not going to be any good. If it is it will raise many questions. Also the announcement talks about exclusivity period. Do you by any chance know that if we are in this period now? If yes then any changes we have to pay a break fee.
Ann: Mayne Pharma enters Scheme Implementation Deed with Cosette, page-107
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$5.26 |
Change
0.040(0.77%) |
Mkt cap ! $426.5M | |||
| Open | High | Low | Value | Volume |
| $5.29 | $5.29 | $5.15 | $57.87K | 11.05K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 2467 | $5.26 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.28 | 121 | 3 |
View Market Depth
| Last trade - 12.26pm 18/06/2025 (20 minute delay) ? |
| MYX (ASX) Chart |